Cogentix Medical, Inc.
CGNT
CGNT was delisted on the 20th of April, 2018.
34 hedge funds and large institutions have $13.4M invested in Cogentix Medical, Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 10 closing their positions.
5% less capital invested
Capital invested by funds: $14.1M → $13.4M (-$635K)
19% less funds holding
Funds holding: 42 → 34 (-8)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$584K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$465K |
| 3 |
BlackRock
New York
|
+$103K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$48.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$28.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$497K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$326K |
| 3 |
Millennium Management
New York
|
-$66.9K |
| 4 |
SIM
Spark Investment Management
New York
|
-$52K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$51.2K |
CGNT Hedge Fund Activity: Q2 2017 in Review
34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q2 2017, worth a combined $13.4M — down 4.5% from $14.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CGNT and 2 opened new positions — a net loss of 8 holders — while 12 trimmed existing stakes and 8 added.
The largest buyer was Broadfin Capital, adding an estimated $584K. The largest seller was Vanguard Group, cutting an estimated $497K.
- 34 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q2 2017, down from 42 in Q1 2017.
- Funds reported $13.4M of Cogentix Medical, Inc. stock for Q2 2017, down 4.5% quarter-over-quarter.
- 2 funds opened new Cogentix Medical, Inc. positions in Q2 2017 and 10 closed out, a net change of -8 holders.
- The largest Cogentix Medical, Inc. buyer in Q2 2017 was Broadfin Capital, an estimated $584K added.
- The largest Cogentix Medical, Inc. seller in Q2 2017 was Vanguard Group, an estimated $497K sold.
Based on aggregated 13F filings for Q2 2017.